AllianceBernstein’s Ocugen OCGN Stock Holding History

AllianceBernstein’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-138,730	Closed	-$98K	–	3299
2025 Q1	$98K	Hold	138,730	–	–	﹤0.01%	3070
2024 Q4	$112K	Hold	138,730	–	–	﹤0.01%	3117
2024 Q3	$138K	Hold	138,730	–	–	﹤0.01%	3091
2024 Q2	$215K	Buy	+138,730	New	+$216K	﹤0.01%	3010
2023 Q2	–	Sell	-296,900	Closed	-$253K	–	3219
2023 Q1	$253K	Hold	296,900	–	–	﹤0.01%	2834
2022 Q4	$386K	Buy	296,900 +103,700	+54%	+$162K	﹤0.01%	2770
2022 Q3	$344K	Hold	193,200	–	–	﹤0.01%	2807
2022 Q2	$439K	Hold	193,200	–	–	﹤0.01%	2735
2022 Q1	$638K	Buy	193,200 +600	+0.3%	+$2.11K	﹤0.01%	2577
2021 Q4	$876K	Hold	192,600	–	–	﹤0.01%	2518
2021 Q3	$1.38M	Hold	192,600	–	–	﹤0.01%	2365
2021 Q2	$1.55M	Buy	+192,600	New	+$1.63M	﹤0.01%	2329

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rinkey Investments San Diego, California $425M AUM 14.99% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AllianceBernstein's OCGN Position: Q2 2025 in Review

AllianceBernstein sold out of Ocugen (OCGN) in Q2 2025, closing a stake of 138,730 shares — an estimated $98K sold.

AllianceBernstein first reported a position in OCGN in Q2 2021 and held it in 12 quarters. The position peaked at $1.55M in Q2 2021. 104 funds tracked by Wall St. Rank hold OCGN as of Q2 2025.

AllianceBernstein reported no remaining Ocugen position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 138,730 Ocugen shares in Q2 2025, an estimated $98K.
AllianceBernstein first reported a position in Ocugen in Q2 2021 and held it in 12 quarters.
AllianceBernstein's Ocugen position peaked at $1.55M in Q2 2021.
104 funds tracked by Wall St. Rank held Ocugen as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.